News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
145,778 Results
Type
Article (6634)
Company Profile (48)
Press Release (139096)
Section
Business (37854)
Career Advice (160)
Deals (9055)
Drug Delivery (11)
Drug Development (21786)
Employer Resources (17)
FDA (3670)
Job Trends (3246)
News (72314)
Policy (6410)
Tag
Academia (502)
Accelerated approval (1)
Adcomms (5)
Allergies (18)
Alliances (9230)
ALS (24)
Alzheimer's disease (282)
Antibody-drug conjugate (ADC) (18)
Approvals (3713)
Artificial intelligence (26)
Autoimmune disease (3)
Automation (1)
Bankruptcy (59)
Best Places to Work (2900)
BIOSECURE Act (1)
Biosimilars (21)
Biotechnology (34)
Bladder cancer (29)
Brain cancer (3)
Breast cancer (91)
Cancer (681)
Cardiovascular disease (65)
Career advice (139)
Career pathing (5)
CAR-T (28)
Cell therapy (90)
Cervical cancer (7)
Clinical research (18365)
Collaboration (172)
Compensation (534)
Complete response letters (3)
COVID-19 (537)
CRISPR (10)
C-suite (56)
Cystic fibrosis (32)
Data (804)
Depression (12)
Diabetes (97)
Diagnostics (1321)
Digital health (3)
Diversity, equity & inclusion (7)
Drug discovery (22)
Drug pricing (6)
Drug shortages (2)
Duchenne muscular dystrophy (21)
Earnings (15662)
Editorial (4)
Employer branding (3)
Employer resources (18)
Events (23904)
Executive appointments (161)
FDA (4057)
Friedreich's ataxia (1)
Frontotemporal dementia (2)
Funding (190)
Gene editing (28)
Gene therapy (75)
GLP-1 (195)
Government (810)
Guidances (40)
Healthcare (4389)
Huntington's disease (6)
IgA nephropathy (6)
Immunology and inflammation (24)
Indications (15)
Infectious disease (575)
Inflammatory bowel disease (37)
Influenza (17)
Intellectual property (19)
Interviews (19)
IPO (5729)
IRA (5)
Job creations (553)
Job search strategy (120)
Kidney cancer (5)
Labor market (2)
Layoffs (82)
Leadership (3)
Legal (1160)
Liver cancer (27)
Lung cancer (131)
Lymphoma (51)
Machine learning (1)
Management (6)
Manufacturing (86)
MASH (19)
Medical device (2502)
Medtech (2502)
Mergers & acquisitions (3538)
Metabolic disorders (174)
Multiple sclerosis (12)
NASH (3)
Neurodegenerative disease (18)
Neuropsychiatric disorders (4)
Neuroscience (405)
NextGen: Class of 2025 (1351)
Non-profit (1477)
Now hiring (5)
Obesity (62)
Opinion (31)
Ovarian cancer (20)
Pain (18)
Pancreatic cancer (27)
Parkinson's disease (34)
Partnered (1)
Patents (45)
Patient recruitment (22)
Peanut (7)
People (11197)
Pharmaceutical (8)
Phase I (5038)
Phase II (8152)
Phase III (6728)
Pipeline (372)
Policy (11)
Postmarket research (755)
Preclinical (2175)
Press Release (14)
Prostate cancer (26)
Psychedelics (6)
Radiopharmaceuticals (56)
Rare diseases (109)
Real estate (1164)
Recruiting (4)
Regulatory (5006)
Reports (7)
Research institute (480)
Resumes & cover letters (23)
Rett syndrome (1)
RSV (9)
Schizophrenia (21)
Series A (21)
Series B (8)
Service/supplier (4)
Sickle cell disease (14)
Spinal muscular atrophy (27)
Sponsored (5)
Startups (712)
State (1)
Stomach cancer (1)
Supply chain (9)
Tariffs (3)
The Weekly (4)
Vaccines (130)
Venture capitalists (7)
Weight loss (23)
Women's health (5)
Worklife (2)
Date
Today (75)
Last 7 days (286)
Last 30 days (883)
Last 365 days (8902)
2025 (3161)
2024 (9388)
2023 (10237)
2022 (12609)
2021 (14013)
2020 (12609)
2019 (10645)
2018 (7897)
2017 (7224)
2016 (6293)
2015 (7475)
2014 (5408)
2013 (4345)
2012 (4661)
2011 (5063)
2010 (4584)
Location
Africa (104)
Alabama (3)
Arizona (38)
Arkansas (1)
Asia (7159)
Australia (1238)
California (1715)
Canada (494)
China (117)
Colorado (55)
Connecticut (92)
Delaware (66)
Europe (20433)
Florida (280)
Georgia (40)
Idaho (8)
Illinois (120)
India (7)
Indiana (112)
Iowa (2)
Japan (52)
Kansas (28)
Kentucky (13)
Louisiana (1)
Maine (5)
Maryland (252)
Massachusetts (1282)
Michigan (36)
Minnesota (69)
Missouri (26)
Montana (2)
Nebraska (5)
Nevada (16)
New Hampshire (5)
New Jersey (507)
New Mexico (2)
New York (461)
North Carolina (972)
North Dakota (4)
Northern California (822)
Ohio (79)
Oklahoma (3)
Oregon (6)
Pennsylvania (347)
Puerto Rico (2)
Rhode Island (6)
South America (227)
South Carolina (20)
Southern California (629)
Tennessee (8)
Texas (231)
United States (6963)
Utah (49)
Virginia (36)
Washington D.C. (33)
Washington State (156)
West Virginia (1)
Wisconsin (19)
145,778 Results for "c lecta".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
c-LEcta Reports Record Year With Significant Growth - Aug 23, 2022
c-LEcta, a global biotechnology company with technology leadership in enzyme engineering and bioprocess development, successfully continued its dynamic business development in fiscal year 2021.
August 23, 2022
·
6 min read
Deals
c-LEcta Announces That It Has Reached Agreement to Be Acquired by Kerry Group
c-LEcta has announced that it has reached an agreement with Kerry Group for it to acquire a majority shareholding of the company.
February 15, 2022
·
3 min read
c-LEcta Expands Product Range to Include Additional Enzyme NuCLEANase®
c-LEcta, a global biotechnology company with technology leadership in enzyme engineering and bioprocess development, is launching a newly developed enzyme product.
November 11, 2021
·
3 min read
c-LEcta Continues Its Growth in 2021 and Sees Itself Excellently Positioned for the Future With the ENESYZ Technology Platform
c-LEcta, a global biotechnology company with technology leadership in enzyme engineering and bioprocess development, continued its growth in 2021.
December 16, 2021
·
4 min read
Policy
c-LEcta: Drug Master File for the Use of the Enzyme DENARASE® in the Pharmaceutical Industry Accepted by the US FDA
c-LEcta, a global biotechnology company with technology leadership in enzyme engineering and bioprocess development, has announced the submission of a Master File for its best-selling product DENARASE®.
August 31, 2021
·
3 min read
Policy
c-LEcta: European Dossiers Submitted for Approval of New Enzymes in the Food Industry
c-LEcta, a global biotechnology company with technology leadership in enzyme engineering and bioprocess development, has submitted dossiers for two newly developed enzymes in the food sector.
May 26, 2021
·
4 min read
Business
c-LEcta exceeds EUR 10 million in revenue with significantly higher EBITDA
c-LEcta, a global biotechnology company with technology leadership in enzyme engineering and bioprocess development, managed to successfully continue its growth in the fiscal year 2020 despite a challenging year overall.
June 15, 2021
·
5 min read
EXCiPACT Certification for c-LEcta’s High Production Standards
Certification is deemed an international seal of approval and guarantees the highest quality standards for pharmaceutical excipients and other critical materials used by the pharmaceutical industry, such as DENARASE, a c-LEcta enzyme product that is used in the production of biopharmaceuticals and vaccines
March 2, 2021
·
5 min read
Press Releases
EpiBiologics Presents First Data on c-Met Degrading Bispecific Antibody
April 29, 2025
·
3 min read
Press Releases
EnteroBiotix Presents Positive IBS-C Data at Digestive Disease Week® 2025
May 7, 2025
·
4 min read
1 of 14,578
Next
